All lobbying filings

LMH STRATEGIC SOLUTIONS

Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Biopharmaceutical company.

Filing 2nd Quarter - Termination

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $20,000.00 income · posted Jul 15, 2025

Official filing document

Bills named in this filing 2

HR 1509
Accelerating Kids’ Access to Care Act of 2025
S 752
Accelerating Kids’ Access to Care Act

Lobbying activity 1

Health Issues

Access for inpatient gene therapies Monitor newborn screening issues. Pediatric Review Reauthorization. H.R.1509/S.752 - Accelerating Kids Access to Care Act of 2025.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.